Log In
BCIQ
Print this Print this
 

1995057

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionTumor necrosis factor receptor-1 (TNFR1) domain antibody
Molecular Target Tumor necrosis factor (TNF) receptor 1 (TNFRSF1A) (TNFR1) (CD120a)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationAcute lung injury
Indication DetailsTreat acute lung injury
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today